PP01.25: Exploring A>I(G) RNA Editing Patterns Linked to Cisplatin Sensitivity in LUAD Patients with Non-Actionable Mutations: Potential Biomarkers for Precision Oncology
Back to course
Pdf Summary
Asset Subtitle
Yanara Bernal
Keywords
RNA editing
cisplatin sensitivity
lung adenocarcinoma
LUAD
biomarkers
precision oncology
RAC1
TCGA
GDSC
RNA sequencing
Powered By